Mexidol®. Rehabilitation after coronavirus

Time codes:
  • 00:00

    Influence Covid-19 on neurological diseases

  • 00:45

    The role of breathing gymnastics in rehabilitation

  • 01:18

    The use of Mexidol® in the treatment of Covid-19

Kovalchuk Vitaly Vladimirovich -MD, professor, chairman of the Society of Rehabilitologists of St. Petersburg, head. department of neurological rehabilitation of St. Petersburg GBUZ "City Hospital No. 38 named after N.A. Semashko "

Announcement:

Patients with the diagnosis of COVID-19 require special attention and the multicomponent process of conducting, the basis of which is the timely and adequate use of drug treatment and rehabilitation. Covid-19 can be associated with such lesions of the central and peripheral nervous system as, for example, encephalitis, meningitis, leukoencephalopathy and Guine - Barre syndrome. The quality of the patient’s recovery depends on the correct rehabilitation. Mexidol ® after coronavirus is an integral part of patient therapy with the consequences of a new infection.

Find out more in the video “ Rehabilitation after Covid-19 ”.

Block of articles on this topic

The use of Mexidol in patients with chemical and covid-19

Author:
A.I. Fedin

FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

Personal: the role of free-radical oxidation, hypoxia and their correction in the pathogenesis of Covid-19

Authors:
A.V. Schulkin, A.A. Filimonova

FGBOU in the Ryazan State Medical University named after Acad. I.P. Pavlova "of the Ministry of Health of Russia

Personal: asthenia and cognitive disorders against the background of the transformed infection Covid-19: possible correction routes

Author:
Ostroumova T.M.

FGAOU in "First Moscow State Medical University named after THEM. Sechenov "Ministry of Health of Russia (Sechenov University), Moscow, Russia

Personal: Opportunities for increasing the effectiveness of patients with chronic brain ischemia against the background of COVID-19

Authors:
V.V. Kovalchuk, I.I. Ershova, N.V. Molodovskaya

St. Petersburg GBUZ "City Hospital No. 38 named after N.A. Semashko ", St. Petersburg, Russia

Personal: antioxidants/antihypoxants-missing puzzle of effective pathogenetic therapy of patients with COVID-19

Author:
T.A. Voronin

Research Institute of Pharmacology. V.V. Zakusova, Moscow, Russian Federation

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com